Drug-induced burning mouth syndrome: A new clinico-pathological entity?

Journal of Headache and Pain

Volumn 13, Issue 8, 2012, Pages 685-686

  Fortuna, Giulio ^a   Pollio, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

ALGORITHM; BURNING MOUTH SYNDROME; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG INDUCED DISEASE; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; BURNING MOUTH SYNDROME; CARBIDOPA; FEMALE; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 84870313980     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-012-0486-x     Document Type: Letter

References (10)

1. Coon EA, Laughlin RS (2012) Burning mouth syndrome in Parkinson's disease: Dopamine as cure or cause? J Headache Pain 13:255-257
2. Zakrzewska JM (2010) Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother 11:1239-1254
3. Buchanan JA, Zakrzewska JM (2010) Burning mouth syndrome. Clin Evid pii:1301
4. Agbabiaka TB, Savović J, Ernst E (2008) Methods for causality assessment of adverse drug reactions: A systematic review. Drug Saf 31:21-37
5. Farcas A, Bojita M (2009) Adverse drug reactions in clinical practice: A causality assessment of a case of drug-induced pancreatitis. J Gastrointestin Liver Dis 18:353-358
6. Kelly WN (2003) The quality of published adverse drug event reports. Ann Pharmacother 37:1774-1778
7. Clifford TJ, Warsi MJ, Burnett CA, Lamey PJ (1998) Burning mouth in Parkinson's disease sufferers. Gerodontology 15:73-78
8. Lemke MR (2008) Depressive symptoms in Parkinson's disease. Eur J Neurol 15(Suppl 1):21-25
9. Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 24:1333-1338
10. Schiavone V, Adamo D, Ventrella G et al (2012) Anxiety, depression, and pain in burning mouth syndrome: First chicken or egg? Headache 52:1019-1025